CD59 mRNA transcription analysis reveals that multiple cancers, such as diffuse large B cell lymphoma (DLBC), glioblastoma multiforme (GBM), pancreatic adenocarcinoma (PAAD), skin cutaneous melanoma (SKCM), and thymoma (THYM) exhibit significantly higher mRNA expression of CD59 (Figure 1B). This evidence concerns the gene CD59 and diffuse large B-cell lymphoma.